De-Risk Your Early-Stage MedTech

Address U.S. reimbursement challenges confidently. Hit your milestones. Land your next round.

Coustier Advisory helps MedTech innovators achieve widespread reimbursement coverage in the U.S.

I don't know where to start.

Am I using the right codes?

I need help with Reimbursement Strategy.

MedTech Startup Accelerators and Partnerships

Get into the U.S. payer's head so you can develop the right evidence.

Validate the codes you want to use -

or avoid.

Efficient, cost-effective U.S. reimbursement guidance

Insights for MedTech Innovators

Insights to help you validate your pathway, align with payer expectations, and move forward with confidence.

Clinical Trial Reimbursement in the U.S.: FAQs for MedTech Companies

Clinical Trial Reimbursement in the U.S.: FAQs for MedTech Companies

A clear FAQ guide on how MedTech startups can secure Medicare reimbursement for clinical trials—and when it’s worth it. ...more

Evidence Planning ,Featured

March 19, 20254 min read

Beware Basing Your MedTech Pricing on Short-term New Tech Payment Mechanisms

Beware Basing Your MedTech Pricing on Short-term New Tech Payment Mechanisms

New tech payments like NTAP can’t justify long-term pricing. Here’s what MedTech founders need to know. ...more

Coding and Payment Mechanics ,Featured

March 04, 20253 min read

The Hidden Bias in Reimbursement: Why First Movers May Have It Easier

The Hidden Bias in Reimbursement: Why First Movers May Have It Easier

Why do better technologies struggle for reimbursement while outdated ones thrive? Discover the hidden bias in payer decision-making—and why second movers in MedTech face steeper evidence hurdles than ... ...more

Payer Coverage ,Featured

February 06, 20254 min read

Can you help us get our own code?

Yes - and we guide you before, during, and after.

From evaluating whether you need a code, to specialty society engagement, to product positioning and submission strategy, we manage the nuances that matter.

We're generating strong performance data for FDA clearance isn't that enough for coverage decisions too?

Not quite.

The FDA wants to see that your device works — that it's safe and effective. Payers, on the other hand, want proof that your device actually improves patient outcomes in the real world — and that those improvements last.

Can we validate our business model with U.S. healthcare stakeholders?

Yes — through direct feedback.

We set up interviews with payers, physicians, and hospital leaders to validate assumptions or flag red flags early.

I heard of a company getting reimbursed during a clinical trial is that possible?

Absolutely.

Clinical trial reimbursement can offset sponsor costs, validate medical necessity and coding early, and set sites up for success upon commercialization. But there are trade-offs you don’t want to ignore.

How would we get in front of health plans?

We design payer education campaigns, coordinate society introductions, and prepare custom coverage advocacy dossiers.

Helping MedTech innovators achieve widespread reimbursement coverage in the U.S.

© 2025 Coustier Advisory LLC. All rights reserved.

Powered by Rocket Boost